For the quarter ending 2026-03-31, UTGN had $16,234,860 increase in cash & cash equivalents over the period.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income | 23,461,508 | -4,156,683 | 10,270,285 | 11,053,296 |
| Amortization (accretion) of investments | 4,787 | -49,873 | -63,491 | -103,936 |
| Other-than-temporary impairments | - | 725,032 | - | - |
| Realized investment gains, net | 3,548,793 | 74,057 | 1,438,307 | 1,026,768 |
| Change in fair value of equity securities | 28,213,466 | -4,147,411 | 10,691,078 | 15,033,564 |
| Change in allowance from credit losses | -15,000 | -75,000 | - | - |
| Unrealized trading losses included in income | - | - | - | 0 |
| Amortization of cost of insurance acquired | 152,537 | 153,541 | 153,542 | 307,083 |
| Provision for deferred income taxes | 4,739,351 | -1,645,072 | 1,255,902 | 3,237,621 |
| Depreciation and depletion | 494,447 | 249,907 | 272,334 | 757,782 |
| Stock-based compensation | 178,321 | 248,031 | 29,396 | 13,974 |
| Charges for mortality and administration of universal life and annuity products | 1,332,337 | 1,323,666 | 1,345,329 | 2,703,990 |
| Interest credited to account balances | 848,659 | 855,632 | 860,855 | 1,736,139 |
| Change in accrued investment income | 13,025 | -23,253 | 12,395 | -124,419 |
| Change in reinsurance receivables | 2,621,734 | -216,799 | 31,919 | -590,423 |
| Change in policy liabilities and accruals | 2,851,835 | -1,247,329 | -724,355 | -2,112,376 |
| Change in income taxes receivable | 1,521,280 | -15,868 | 1,006,781 | -215,485 |
| Change in other assets and liabilities, net | 1,097,667 | 230,716 | -223,677 | 1,146,472 |
| Trading securities | - | 0 | 0 | 0 |
| Net cash used in operating activities | -2,598,871 | -2,098,912 | -107,120 | -4,313,982 |
| Real estate | - | 0 | 0 | 88,151 |
| Fixed maturities available for sale | 2,242,178 | 3,500,000 | 3,500,000 | 5,500,000 |
| Equity securities | 16,110,094 | 2,053,662 | 2,068,532 | 3,344,765 |
| Mortgage loans | 1,228,381 | 302,286 | 1,039,735 | 2,005,832 |
| Notes receivable | 455,703 | 656,977 | 8,406,430 | 403,484 |
| Policy loans | 245,920 | 310,567 | 261,369 | 564,552 |
| Short-term investments | 2,500,000 | 1,000,000 | 0 | 1,000,000 |
| Total proceeds from investments sold and matured | 22,782,276 | 7,823,492 | 15,276,066 | 12,906,784 |
| Fixed maturities available for sale | 1,706,386 | 1,997,192 | 1,999,631 | 999,219 |
| Equity securities | 717,988 | 2,668,559 | 810,105 | 11,149,087 |
| Trading securities | - | 0 | 0 | 0 |
| Mortgage loans | 441,906 | 159,387 | 301,977 | 985,812 |
| Short-term investments | - | 9,781,441 | 0 | 0 |
| Notes receivable | 0 | 3,875,000 | 250,000 | 1,318,133 |
| Real estate | 0 | 5,276,122 | 50,000 | 467,299 |
| Policy loans | 151,876 | 187,495 | 194,185 | 423,407 |
| Total cost of investments acquired | 3,018,156 | 23,945,196 | 3,605,898 | 15,342,957 |
| Net cash (used in) provided by investing activities | 19,764,120 | -16,121,704 | 11,670,168 | -2,436,173 |
| Policyholder contract deposits | 1,013,884 | 838,883 | 951,544 | 2,052,142 |
| Policyholder contract withdrawals | 1,748,500 | 1,172,751 | 1,126,225 | 1,982,984 |
| Payments of principal on notes payable/line of credit | - | 0 | 0 | 0 |
| Purchase of treasury stock | 195,773 | 262,946 | 316,313 | 203,553 |
| Noncontrolling (distributions) of consolidated subsidiary | - | -97,069 | - | - |
| Net cash used in financing activities | -930,389 | -693,883 | -490,994 | -134,395 |
| Net increase (decrease) in cash and cash equivalents | 16,234,860 | -18,914,499 | 11,072,054 | -6,884,550 |
| Cash and cash equivalents at beginning of period | 30,536,972 | 49,451,471 | 45,263,967 | - |
| Cash and cash equivalents at end of period | 46,771,832 | 30,536,972 | 49,451,471 | - |
UTG INC (UTGN)
UTG INC (UTGN)